Deccan Health Care Limited (BOM:542248)
India · Delayed Price · Currency is INR 12.66
-0.42 (-3.21%)
At close: Jul 28, 2026
Deccan Health Care Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 24.88 | 11.59 | 14.93 | 3.06 | 3.23 |
Depreciation & Amortization | 14.64 | 14.53 | 14.67 | 14.28 | 14.73 |
Loss (Gain) From Sale of Assets | 1.4 | - | - | - | - |
Other Operating Activities | 12.31 | 4.33 | 8.26 | -6.56 | 1.17 |
Change in Accounts Receivable | -44.51 | -27.28 | 21.03 | 7.69 | -3.57 |
Change in Inventory | -43.6 | 31.66 | 10.57 | -2.5 | -15.24 |
Change in Accounts Payable | 107.88 | 46.77 | -41.78 | 26.22 | 1.5 |
Change in Income Taxes | - | - | - | 2.18 | - |
Change in Other Net Operating Assets | -109.2 | -147.64 | -152.48 | -112.02 | -7.54 |
Operating Cash Flow | -36.21 | -66.05 | -124.81 | -67.65 | -5.73 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -25.67 | -1.42 | -3.11 | - | -1.12 |
Sale of Property, Plant & Equipment | 3.32 | - | - | 2.54 | - |
Other Investing Activities | -0.13 | 0.06 | 0.11 | 0.16 | 0.53 |
Investing Cash Flow | -22.48 | -1.37 | -3 | 2.7 | -0.49 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 9.99 | 0.44 | - | - | - |
Long-Term Debt Issued | 22.6 | - | 5.9 | 4.58 | 2.19 |
Total Debt Issued | 32.59 | 0.44 | 5.9 | 4.58 | 2.19 |
Short-Term Debt Repaid | - | - | -7.36 | -0.72 | - |
Long-Term Debt Repaid | -4.42 | -3.04 | - | - | - |
Total Debt Repaid | -4.42 | -3.04 | -7.36 | -0.72 | - |
Net Debt Issued (Repaid) | 28.17 | -2.61 | -1.47 | 3.86 | 2.19 |
Issuance of Common Stock | 13.24 | 30.49 | 99.34 | 50 | - |
Other Financing Activities | -1.81 | 52.18 | 38.54 | -1.26 | -1.52 |
Financing Cash Flow | 39.6 | 80.07 | 136.41 | 52.61 | 0.67 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | -19.1 | 12.65 | 8.61 | -12.34 | -5.55 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -61.89 | -67.47 | -127.92 | -67.65 | -6.85 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -7.56% | -8.99% | -21.42% | -15.02% | -2.07% |
Free Cash Flow Per Share | -2.51 | -2.62 | -6.87 | -5.30 | -0.44 |
Levered Free Cash Flow | -70.94 | -66.14 | -129.19 | -60.31 | -2.35 |
Unlevered Free Cash Flow | -68.65 | -65.78 | -128.84 | -59.77 | -1.64 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 3.66 | 0.58 | 0.56 | 0.86 | 1.52 |
Cash Income Tax Paid | 0.17 | 0.12 | 0.1 | 2.18 | 2.51 |
Change in Working Capital | -89.43 | -96.49 | -162.66 | -78.42 | -24.85 |